Africa

Africa’s first Lassa fever vaccine clinical trial begins in Ghana

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial (LSV-002), ongoing at the Noguchi Memorial Institute for Medical Research in Accra, Ghana, is the first vaccine clinical trial for Lassa Fever to be conducted in West

Ghana, Ivory Coast get COVI-19 vaccine ahead of Nigeria

As government officials in Nigeria continue to promise citizens that doses of COVID-19 vaccines will soon become available in the country, Ghana has become the first to receive COVID-19 vaccine on the continent through the Gavi and WHO-led COVAX platform. The vaccines arrived on a flight from Mumbai, via Dubai, where the flight also collected a shipment of syringes from a Gavi-funded stockpile at UNICEF’s regional Supply Hub. In a statement, COVAX today announced that 600,000 doses of the AstraZeneca/Oxford vaccine

Ebola vaccination exercise kicks off in Guinea

Ebola vaccination of people at high risk kicked off today in Guinea as the emergency response was escalated to counter the spread of the virus that re-emerged in the country a little more than a week ago for the first time since 2016. The vaccination was launched in Gouecke, a rural community in N’Zerekore prefecture where the first cases were detected on 14 February. The Minister of Health and Public Hygiene of Guinea, General Remy Lamah, the United Nations Resident Coordinator,

For the 12th time, Ebola outbreak announced in DR Congo

The Ministry of Health of the Democratic Republic of the Congo (DRC) today announced that a new case of Ebola has been detected in Butembo, a city in North Kivu Province, where a previous outbreak was declared over in June 2020. The Butembo branch of the National Institute of Biomedical Research (INRB) confirmed Ebola in samples taken from a patient with Ebola-like symptoms who had sought treatment at a local health centre. The woman was the wife of an Ebola survivor.

There is an approved treatment for Ebola

The U.S. Food and Drug Administration has approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children. Ebanga blocks binding of the virus to the cell receptor, preventing its entry into the cell. FDA granted the approval to Ridgeback Biotherapeutics, LP. Ebanga was granted an Orphan Drug designation, which provides incentives to assist and encourage drug development for rare diseases. Additionally, the agency granted Ebanga a Breakthrough Therapy designation. “Patients who receive Ebanga should avoid

Nigeria, others to benefit from US govt’s $4bn COVID-19 vaccine fund

Africa’s most populous country, Nigeria, and other countries across the continent and beyond that qualify to enjoy support from Gavi, the Vaccine Alliance will benefit from the final approval of the United States’ commitment to provide Gavi with US$ 4 billion in COVID-19 supplemental funding. These resources, which were included in a larger omnibus funding package, will ensure that lower-income economies have equitable access to safe and effective COVID-19 vaccines, helping to end the acute phase of the pandemic. In a statement, Gavi

3 out 4 abortions in Africa are unsafe – WHO

According to the World Health Organisation (WHO), about 75% of all abortions in Africa are unsafe. It added that across the world, women in Africa have the highest risk of dying from unsafe abortion. While the WHO recently raised alarm regarding unsafe abortion, the situation is most severe in Africa where abortion is largely unsafe and the risk of dying is highest but this does not mean that it is not a global crisis. According to the WHO, 45% of

New drug outperforms PreP in preventing HIV among African women

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has announced that it is strongly encouraged by new study results showing that the antiretroviral medicine cabotegravir, which is administered by injection every two months, prevents HIV among women. The study shows that the long-acting injections among women in sub-Saharan Africa were 89% more efficient in preventing HIV compared to daily tablets of pre-exposure prophylaxis (PrEP). “These results are hugely significant. UNAIDS has long been calling for additional, acceptable and effective HIV prevention options

Banding together is the only way Africa will beat COVID-19

As of 15th October 2020, the continent has a remarkably low 4.2% of the global burden of the disease and just a little above 3.5% of deaths. In this opinion piece, Africa CDC Director Dr. John Nkengasong, and AU Commissioner Amira Elfadil Mohammed Elfadil describe what the continent of Africa still needs to do to beat the COVID-19 pandemic. Everyone knows by now that due to a combination of leadership, environment, social ecology, demographics and as yet unknown biological and other